Literature DB >> 6793817

Immunopotentiation and inhibition of herpes virus activation during therapy with lithium carbonate.

J Lieb.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6793817     DOI： 10.1016/0306-9877(81)90043-8

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN： 0306-9877            Impact factor:   1.538


× No keyword cloud information.
  2 in total

1.  Evaluation of lithium as an inhibitory agent of herpes simplex virus in cell cultures and during reactivation of latent infection in rabbits.

Authors:  M D Trousdale; Y J Gordon; A C Peters; T I Gropen; E Nelson; A B Nesburn
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

2.  Does Lithium Deserve a Place in the Treatment Against COVID-19? A Preliminary Observational Study in Six Patients, Case Report.

Authors:  Carlos Spuch; Marta López-García; Tania Rivera-Baltanás; Daniela Rodrígues-Amorím; José M Olivares
Journal:  Front Pharmacol       Date:  2020-08-27       Impact factor: 5.810
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.